Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Identification and diagnostic potential of hsa_circ_101303 in colorectal cancer: unraveling a regulatory network

    The role of novel circular RNAs (circRNAs) in colorectal cancer (CRC) remains to be determined. This study aimed to identify a novel circRNA involved in CRC pathogenesis, assess its diagnostic value, and const...

    Ke-zhi Li, **ao-min Liao, Si-qi Li, Hao-tang Wei, Zhi-jian Liang, Liu-xin Ge in BMC Cancer (2024)

  2. Article

    Open Access

    Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients

    The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infected a substantial proportion of Chinese population, and understanding the factors underlying the severity of the dis...

    Lin Wang, Jia-Bao Cao, Bin-Bin **a, Yue-Juan Li in Signal Transduction and Targeted Therapy (2023)

  3. Article

    Open Access

    S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway

    Cell senescence deters the activation of various oncogenes. Induction of senescence is, therefore, a potentially effective strategy to interfere with vital processes in tumor cells. Sphingosine-1-phosphate rec...

    Yi-** Tao, Heng-Yan Zhu, Qian-Yuan Shi, Cai-**a Wang, Yu-**n Hua, Han-Yin Hu in Oncogene (2023)

  4. Article

    Open Access

    Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma

    CANT1, as calcium-activated protein nucleotidase 1, is a kind of phosphatase. It is overexpressed in some tumors and related to poor prognosis, but few studies explore its function and carcinogenic mechanism i...

    Ting Liu, Zhi-zhao Li, Lei Sun, Kun Yang, Jia-min Chen, **ao-yi Han in BMC Cancer (2023)

  5. Article

    Open Access

    Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

    EMERGING-CTONG 1103 showed improved progression-free survival (PFS) with neoadjuvant erlotinib vs. chemotherapy for patients harbouring EGFR sensibility mutations and R0 resected stage IIIA-N2 non-small cell l...

    Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen in Signal Transduction and Targeted Therapy (2023)

  6. No Access

    Article

    The prevalence of hypophosphatemia and refeeding-related hypophosphatemia in hospitalized patients requiring parental nutrition: a retrospective study

    Hypophosphatemia might cause respiratory and heart failure and even death. We aimed to evaluate risk factors for hypophosphatemia and refeeding-related hypophosphatemia in patients requiring parental nutrition...

    Yi-quan Zhou, **ao-min Zhang, Zhi-qi Chen, Jia-lu Wang in Supportive Care in Cancer (2022)

  7. Article

    Open Access

    Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma

    Immune checkpoint blockade resistance narrows the efficacy of cancer immunotherapies, but the underlying mechanism remains elusive. Delineating the inherent mechanisms of anti-PD1 resistance is important to im...

    Jia-Cheng Lu, Peng-Fei Zhang, **ao-Yong Huang in Journal of Hematology & Oncology (2021)

  8. Article

    Open Access

    Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma

    Although adjuvant transcatheter arterial chemoembolization (TACE) for resected hepatocellular carcinoma (HCC) may improve survival for some patients, identifying which patients can benefit remains challenging....

    Lei Liang, Chao Li, Ming-Da Wang, Hong Wang in Journal of Hematology & Oncology (2021)

  9. Article

    Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates

    The ongoing coronavirus disease 2019 (COVID-19) pandemic caused more than 96 million infections and over 2 million deaths worldwide so far. However, there is no approved vaccine available for severe acute resp...

    Yan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, Xue Hu, Hua-Jun Zhang in Virologica Sinica (2021)

  10. Article

    Open Access

    The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

    The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH) on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation (allo-HSCT) f...

    **ao-hui Zhang, **g Chen, Ming-Zhe Han, He Huang in Journal of Hematology & Oncology (2021)

  11. Article

    Open Access

    circHMGCS1–016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma

    Accumulating evidence indicates that circRNAs may serve as essential regulators in the progression of several human cancers, but the function and mechanism of circRNAs in intrahepatic cholangiocarcinoma (ICC) ...

    Ya-** Xu, Ze-Ning Dong, Si-Wei Wang in Journal of Experimental & Clinical Cancer … (2021)

  12. Article

    Open Access

    Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

    Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SAR...

    Huijie Bian, Zhao-Hui Zheng, Ding Wei in Signal Transduction and Targeted Therapy (2021)

  13. Article

    Open Access

    Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses

    Currently, there is no strong evidence of the well-established biomarkers for immune checkpoint inhibitors (ICIs) in nasopharyngeal carcinoma (NPC). Here, we aimed to reveal the heterogeneity of tumour microen...

    Yu-Pei Chen, Jia-Wei Lv, Yan-** Mao, **ao-Min Li, Jun-Yan Li in Molecular Cancer (2021)

  14. No Access

    Article

    Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status

    Prior studies have suggested that for leukemia patients with high-risk features, haplo-identical-hematopoietic stem cell transplantation (HID-HSCT) has a stronger anti-leukemia effect compared with HSCT using ...

    Yue Lu, Yan-Li Zhao, Jian-** Zhang, Min **ong, **ng-Yu Cao in Annals of Hematology (2020)

  15. Article

    Open Access

    Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study

    Rearranged during transfection (RET) has been proven to be a tumorigenic target in non-small cell lung cancers (NSCLCs). In RET-rearranged NSCLCs, molecular features and their impact on prognosis were not well il...

    Chang Lu, **ao-Rong Dong, Jun Zhao, Xu-Chao Zhang in Journal of Hematology & Oncology (2020)

  16. Article

    Open Access

    VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer

    VEGF/VEGFR2 pathway is the central therapeutic target in anti-angiogenic treatment in multiple cancers. However, little work has been carried out concerning the pro-malignancy functions of VEGFR2 that are inde...

    Lian Lian, **ang-Li Li, Meng-Dan Xu, **an-Min Li, Meng-Yao Wu, Yan Zhang in BMC Cancer (2019)

  17. No Access

    Article

    Chinese guidelines for treatment of adult primary immune thrombocytopenia

    Primary immune thrombocytopenia (ITP) is a bleeding disorder commonly encountered in clinical practice. The International Working Group (IWG) on ITP has published several landmark papers on terminology, defini...

    **n-guang Liu, **ao-chuan Bai, Fang-** Chen in International Journal of Hematology (2018)

  18. Article

    Open Access

    Signaling protein signature predicts clinical outcome of non-small-cell lung cancer

    Non-small-cell lung cancer (NSCLC) is characterized by abnormalities of numerous signaling proteins that play pivotal roles in cancer development and progression. Many of these proteins have been reported to b...

    Bao-Feng **, Fan Yang, **ao-Min Ying, Lin Gong, Shuo-Feng Hu, Qing Zhao in BMC Cancer (2018)

  19. Article

    Open Access

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

    Casey Ager, Matthew Reilley, Courtney Nicholas in Journal for ImmunoTherapy of Cancer (2016)

  20. Article

    Open Access

    Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis

    To identify the radiation volume effect and significant dosimetric parameters for temporal lobe injury (TLI) and determine the radiation dose tolerance of the temporal lobe (TL) in nasopharyngeal carcinoma (NP...

    Ying Sun, Guan-Qun Zhou, Zhen-Yu Qi, Li Zhang, Shao-Min Huang, Li-Zhi Liu in BMC Cancer (2013)

previous disabled Page of 2